Thimet oligopeptidase as a potential CSF biomarker for Alzheimer's disease: A cross‐platform validation study
Abstract INTRODUCTION Our previous antibody‐based cerebrospinal fluid (CSF) proteomics study showed that Thimet oligopeptidase (THOP1), an amyloid beta (Aβ) neuropeptidase, was increased in mild cognitive impairment with amyloid pathology (MCI‐Aβ+) and Alzheimer's disease (AD) dementia compared...
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Makale |
| Dil: | English |
| Baskı/Yayın Bilgisi: |
Wiley
2023-07-01
|
| Seri Bilgileri: | Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring |
| Konular: | |
| Online Erişim: | https://doi.org/10.1002/dad2.12456 |